Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia causes significant emotional distress and psychological issues, requiring combined skin and mental health treatment.

Advancements in hair biology include new treatments and tools for hair growth and alopecia.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Most skin changes during pregnancy go away after giving birth.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

The document explains different hair loss types and treatments, emphasizing diagnosis through examination and tests, and specific treatments for each condition.

Dermatologists are more comfortable and proactive in treating male pattern hair loss than primary care physicians.

Cosmetic foam product reduces hair loss and increases hair density in men.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

Finasteride significantly increases scalp hair and prevents hair loss in young and middle-aged men.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

The gene Foxn1 is important for hair growth, and understanding it may lead to new alopecia treatments.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Low vitamin D levels can significantly contribute to hair loss, especially in women aged 35-45. Correcting these levels early may help prevent and treat this condition.

Finasteride is a safe and effective long-term treatment for male hair loss, especially when started early.

Metformin is less effective in men with early-onset hair loss.

Young males with severe early-onset hair loss may have a higher risk of metabolic syndrome.

Young men with early hair loss and high SAA3 levels are at higher risk for heart disease.

Androgenetic alopecia may be linked to metabolic syndrome.

Men with early-onset hair loss have less cardiometabolic benefit from bromocriptine.

Smoking increases the risk of male pattern hair loss.

Early hair loss may indicate prostate issues.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.